Yi Huang
- Cancer Research top 5%
- MicroRNA in disease regulation 12
- Cancer-related molecular mechanisms research 10
- Molecular Biology top 10%
- RNA modifications and cancer 12
- Extracellular vesicles in disease 7
- Advanced biosensing and bioanalysis techniques 7
- Glycosylation and Glycoproteins Research 6
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 7
-
- Ferroptosis and cancer prognosis 12
- Journals
- Advanced Materials (1 paper)SHILAP Revista de lepidopterología (1 paper)Blood (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Yi Huang
78 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 118
- Cancer Research 399
- Molecular Biology 838
- Oncology 275
- Immunology 144
- Pulmonary and Respiratory Medicine 203
Countries citing papers authored by Yi Huang
This map shows the geographic impact of Yi Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Huang more than expected).
Fields of papers citing papers by Yi Huang
This network shows the impact of papers produced by Yi Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Huang. The network helps show where Yi Huang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yi Huang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 35 | |
| 6 | 2024 | 12 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 10 | |
| 9 | 2023 | 8 | |
| 10 | 2023 | 9 | |
| 11 | 2023 | 1 | |
| 12 | 2023 | 1 | |
| 13 | 2022 | 12 | |
| 14 | 2022 | 11 | |
| 15 | 2021 | 39 | |
| 16 | 2020 | 67 | |
| 17 | 2018 | 11 | |
| 18 | 2017 | 48 | |
| 19 | Laboratory tests and clinical significance of anti-3-hydroxy-3-methylglutaryl coenzyme A reductase antibody | 2016 | 1 |
| 20 | 2012 | 28 |
About Yi Huang
Yi Huang is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 83 papers that have together received 1.4k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (12 papers), Ferroptosis and cancer prognosis (12 papers), RNA modifications and cancer (12 papers), Cancer-related molecular mechanisms research (10 papers), Extracellular vesicles in disease (7 papers), Cancer Immunotherapy and Biomarkers (7 papers), Advanced biosensing and bioanalysis techniques (7 papers) and Glycosylation and Glycoproteins Research (6 papers). The work is most often cited by research in Cancer Research (399 citations), Molecular Biology (838 citations) and Oncology (275 citations). Yi Huang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Heng Zhu, Lili Yu, Cheng‐Yu Liao, Yifeng Tian, Shi Chen, Zuwei Wang, Long Huang, Bojiang Chen, Dan Liu and Jianda Hu. Their work appears in journals such as Advanced Materials, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.